Amid calls to reduce the gap between two doses of Serum Institute of India's COVID-19 vaccine Covishield based on the new findings by Public Health England, the Central government will not take the decision to change the dosage interval immediately, said sources, adding that the authorities will review the scientific evidence for the same.
"There is going to be no changes in the interval between Covishield doses immediately. However, scientific evidence has been collected to review the decision in the coming meeting of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC)," government sources told ANI.
The Union Health Ministry has said there is no need to panic as such decisions will be taken after careful examination by the experts.
"This is a dynamic process. There is no hardcore ideology in Science. Our experts will go through the latest developments and take a call," said Dr VK Paul, Niti Aayog member (Health) during a press briefing on Friday.
In India, the gap between the two doses of Covishield was widened to 12-16 weeks. The decision on widening the gap was based on international studies that claimed the protection offered by the first dose of the Covishield vaccine lasts longer and the second dose can be taken with a greater gap.
Recently, Dr Anthony Fauci, who is the top medical advisor to the United States President, had said that extending intervals between vaccine doses could leave people vulnerable to infection by one of the COVID-19 variants in circulation.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)